1. Home
  2. ELOG vs CLRB Comparison

ELOG vs CLRB Comparison

Compare ELOG & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELOG

Eastern International Ltd. Ordinary Shares

HOLD

Current Price

$1.22

Market Cap

10.2M

Sector

Industrials

ML Signal

HOLD

Logo Cellectar Biosciences Inc.

CLRB

Cellectar Biosciences Inc.

HOLD

Current Price

$2.60

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELOG
CLRB
Founded
2006
2002
Country
China
United States
Employees
N/A
N/A
Industry
Integrated Freight & Logistics
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2M
12.0M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
ELOG
CLRB
Price
$1.22
$2.60
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
17.8K
241.7K
Earning Date
07-17-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$0.29
52 Week High
$3.07
$10.19

Technical Indicators

Market Signals
Indicator
ELOG
CLRB
Relative Strength Index (RSI) 67.35 36.65
Support Level $0.84 N/A
Resistance Level $1.36 $3.40
Average True Range (ATR) 0.10 0.22
MACD 0.03 -0.07
Stochastic Oscillator 69.64 1.85

Price Performance

Historical Comparison
ELOG
CLRB

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products. Its segments are Transportation services and Warehouse subleasing services. The group generates the majority of its revenue from Transportation services.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: